These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 15641038)

  • 1. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
    Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic significance of cathepsin D in primary breast cancer].
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Schaeffer HJ; Stützer H; Bolte A
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):545-51. PubMed ID: 8001750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of lymphangiosis carcinomatosa and malignancy grading in T1/T2-N0 cancers of the breast using 10 or fewer examined axillary lymph nodes].
    Stauch G; Szulfer CC; Hilfrich J; Georgii A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):283-8. PubMed ID: 2721890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of axillary diagnosis in breast cancer from the viewpoint of radiotherapists. The results of a retrospective study of 671 patients].
    Kiricuta IC; Willner J; Kölbl O
    Strahlenther Onkol; 1992 Jul; 168(7):390-6. PubMed ID: 1496449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis.
    Olivotto IA; Jackson JS; Mates D; Andersen S; Davidson W; Bryce CJ; Ragaz J
    Cancer; 1998 Sep; 83(5):948-55. PubMed ID: 9731899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of metastatic axillary involvement in 1446 cases of breast cancer.
    Veronesi U; Luini A; Galimberti V; Marchini S; Sacchini V; Rilke F
    Eur J Surg Oncol; 1990 Apr; 16(2):127-33. PubMed ID: 2323409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dissection of the axilla in modified radical mastectomy.
    Cáceres E; Lingan M; Delgado P
    Surg Gynecol Obstet; 1976 Sep; 143(3):395-7. PubMed ID: 959960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 and apoptosis in lymph node positive breast carcinoma.
    Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC
    Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended radical operations on breast cancer of medial or central location.
    Deemarski LYu ; Seleznev IK
    Surgery; 1984 Jul; 96(1):73-7. PubMed ID: 6740498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Axillary lymph node excision in breast cancer].
    Kubista E
    Gynakol Rundsch; 1989; 29 Suppl 3():16-20. PubMed ID: 2625270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial area as a prognostic indicator for invasive breast carcinoma.
    Simpson JF; Ahn C; Battifora H; Esteban JM
    Cancer; 1996 May; 77(10):2077-85. PubMed ID: 8640673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive].
    Zhang G; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():66-74. PubMed ID: 8702314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
    Kuerer HM; Newman LA; Buzdar AU; Hunt KK; Dhingra K; Buchholz TA; Binkley SM; Ames FC; Feig BW; Ross MI; Hortobagyi GN; Singletary SE
    Am J Surg; 1998 Dec; 176(6):502-9. PubMed ID: 9926779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation of tumor size, lymph node status and prognosis in breast cancer].
    Shen ZZ
    Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):554-7, 589. PubMed ID: 1813258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
    Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
    Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic significance of axillary node metastasis in breast cancer].
    Miura S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():36-42. PubMed ID: 8702309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast preservation versus mastectomy in early breast cancer--1991 update of the GBSG 1--protocol and prognostic factors. The German Breast Cancer Study Group.
    Sauer R; Schauer A; Rauschecker HF; Schumacher M; Gatzemeier W; Sauerbrei W; Dunst J; Seegenschmiedt MH; Marx D
    Strahlenther Onkol; 1992 Apr; 168(4):191-202. PubMed ID: 1574768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.